Is cataract surgery the best way to lower IOP?

Article

Extraction of cataracts lowers intraocular pressure (IOP) to normal levels in glaucoma patients, and may in fact be a better treatment option than combined surgery, according to a study presented at this year's meeting of the Italian Society of Ophthalmology.

Extraction of cataracts lowers intraocular pressure (IOP) to normal levels in glaucoma patients, and may in fact be a better treatment option than combined surgery, according to data presented at this year's meeting of the Italian Society of Ophthalmology.

Richard L. Lindstrom, MD of Minnesota Eye Consultants, US conducted a retrospective review of 588 eyes undergoing cataract extraction with intraocular lens (IOL) implantation in patients with both glaucoma and cataract.

Dr Lindstrom observed IOP reduction in "most" cases. A mean decrease of 7 mmHg was observed in patients with IOP levels of 23–31 mmHg. Patients with higher preoperative IOP levels showed a greater post-surgical IOP reduction.

Dr Lindstrom concluded that the lens plays a more significant role in the development of glaucoma than had previously been acknowledged and that, therefore, except for in cases of severe glaucoma, cataract surgery alone is an appropriate treatment for lowering IOP.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.